Search Within

Center for Pancreatic Cancer Research

Formats
  1. Journal Article (5066)
  2. Meeting Abstract (2484)
  3. Book Section (225)
  4. Review (221)
  5. Editorial (135)
  6. Conference Paper (75)
  7. Correspondence (48)
  8. Research Letter (43)
  9. Miscellaneous (41)
  10. Guidelines (38)
  11. Book Whole (20)
Groups
  1. Department of Medicine (3948)
  2. Solid Tumor Oncology Division (3245)
  3. Surgery (3172)
  4. GSK Faculty (2917)
  5. Epidemiology and Biostatistics (2529)
  6. Gastrointestinal Oncology Service (2300)

More Groups

People
  1. Mithat Gonen (1036)
  2. William Jarnagin (913)
  3. Eileen O'Reilly (796)
  4. Michael D'Angelica (789)
  5. T Peter Kingham (622)
  6. David Kelsen (538)

More People

Years
  1. 2025 (297)
  2. 2024 (497)
  3. 2023 (523)
  4. 2022 (602)
  5. 2021 (555)
  6. 2020 (562)

More Years

Publications
  1. Journal of Clinical Oncology (927)
  2. Annals of Surgical Oncology (397)
  3. Cancer Research (226)
  4. International Journal of Radiation Oncology, Biology, Physics (219)
  5. Laboratory Investigation (209)
  6. Modern Pathology (191)

More Publications

Publishers
  1. American Society of Clinical Oncology (1003)
  2. Springer (843)
  3. Elsevier Inc. (757)
  4. Nature Publishing Group (633)
  5. American Association for Cancer Research (551)
  6. Elsevier Science, Inc. (510)

More Publishers

Results (8396)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)
    Meeting Abstract

    Bergsland, E. K.; Mahoney, M. R.; Asmis, T. R.; Hall, N.; Kumthekar, P.; Maitland, M. L.; Niedzwiecki, D.; Nixon, A. B.; O'Reilly, E. M.; Schwartz, L. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Benefit of early-phase targeted, basket, and immune-based trials for patients with chemorefractory gastrointestinal (GI) cancers
    Meeting Abstract

    Agarwal, R.; Cangemi, N. A.; Epstein, A. S.; Harding, J. J.; Segal, N. H.; Reidy, D. L.; Hyman, D. M.; Saltz, L. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma
    Meeting Abstract

    Abu-Gheida, I.; Patel, A.; Zaid, M.; Elganainy, D.; Javle, M. M.; Raghav, K. P. S.; Vauthey, J. N.; Aloia, T. A.; Tzeng, C. W. D.; Minsky, B. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations
    Meeting Abstract

    Carlo, M. I.; Kemel, Y.; Breen, K.; Cadoo, K. A.; Walsh, M. F.; Abida, W.; Autio, K. A.; Danila, D. C.; Kampel, L. J.; Morris, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of cabiralizumab (cabira) + nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Wang-Gillam, A.; O'Reilly, E. M.; Bendell, J. C.; Wainberg, Z. A.; Borazanci, E. H.; Bahary, N.; O'Hara, M. H.; Beatty, G. L.; Pant, S.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (panNETs)
    Meeting Abstract

    Wu, L.; Reidy, D. L.; Bielska, A.; Kelly, V.; Raj, N. P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • T-cell inflamed gene expression profile (GEP) and PD-Li expression in patients (pts) with esophageal cancer (EC)
    Meeting Abstract

    Steiniche, T.; Rha, S. Y.; Chung, H. C.; Georgsen, J. B.; Ladekarl, M.; Nordsmark, M.; Jespersen, M. L.; Kim, H. S.; Kim, H.; Fein, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save